A survey of therapeutic drug monitoring in a teaching hospital

被引:9
作者
Almohammde, Shahad [1 ]
Alhodian, Hadil [1 ]
Almofareh, Sara [1 ]
Alshehri, Samah [1 ]
Almasri, Diena M. [1 ]
Ghoneim, Ragia H. [1 ]
机构
[1] King Abdulaziz Univ, Fac Pharm, Pharm Practice Dept, 7027 Abdullah Al Sulaiman Rd, Jeddah 222542265, Saudi Arabia
关键词
TDM; Drug Monitoring; Pharmacokinetics; Clinical Pharmacist; Survey; Teaching hospital;
D O I
10.1016/j.sjbs.2020.11.002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Therapeutic drug monitoring (TDM) is one of the tools that aim to improve and ensure the best therapeutic effects while avoiding drug toxicity. This study aimed to identify the clinical utilization and application of TDM at a major teaching hospital in Jeddah. Methods: A cross sectional survey of the clinical utilization and application of TDM at King Abdulaziz University Teaching Hospital across nurses in medical, surgical, pediatric, and intensive care units. The sample size (n = 130) represented 30% of the nursing population. The collection of questionnaires started on the 31st of January 2019 and was completed by the 10th of March 2019. Results: The indication to use TDM was well-known to respondents. However, only 64% of respondents reported collection and measuring of the correct drug levels at a precise sampling time with no specific protocols being followed for each drug. Moreover, only 53% reported that the drug levels were being remeasured and adequately monitored for the right indication and proper sampling time. Regarding the presence of clinical pharmacists, 70% of the respondents indicated that no clinical pharmacist worked in their department. Conclusion: Results demonstrate that appropriate sampling time was not used for the majority of monitored drugs. In the absence of a TDM request form, this finding probably indicates the lack of national or local TDM guidelines. In conclusion, TDM services, which include standardized forms, references, and an active clinical pharmacist will likely improve the application of TDM. (C) 2020 The Authors. Published by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:744 / 747
页数:4
相关论文
共 11 条
  • [1] Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring
    Alhameed, Abrar F.
    Al Khansa, Sara
    Hasan, Hani
    Ismail, Sherine
    Aseeri, Mohammed
    [J]. PHARMACY, 2019, 7 (01):
  • [2] Alkathiri W AH, 2018, J PHARM PHARM, V6
  • [3] Alomi Y.A.H., VALUE HLTH, V19, pA465
  • [4] Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh region
    Alsultan, Mohammed S.
    Mayet, Ahmed Y.
    Khurshid, Fowad
    Al-jedai, Ahmed H.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (04) : 361 - 370
  • [5] [Anonymous], 1998, Am J Health Syst Pharm, V55, P1726, DOI DOI 10.1093/AJHP/55.16.1726
  • [6] Clinical Pharmacist Impact on Care, Length of Stay, and Cost in Pediatric Cystic Fibrosis (CF) Patients
    Cies, Jeffrey J.
    Varlotta, Laurie
    [J]. PEDIATRIC PULMONOLOGY, 2013, 48 (12) : 1190 - 1194
  • [7] Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients
    Griffin, Shawn P.
    Nelson, Joelle E.
    [J]. PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 314 - 321
  • [8] Best practice in therapeutic drug monitoring
    Gross, AS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) : 95 - 99
  • [9] Kang Ju-Seop, 2009, Korean Journal of Internal Medicine, V24, P1, DOI 10.3904/kjim.2009.24.1.1
  • [10] Murphy R.C.M., CANADIAN SOC HOSP PH, V60, P162